Skip to main content
. 2019 Sep 20;235(3):2792–2799. doi: 10.1002/jcp.29183

Figure 3.

Figure 3

JNK‐IN‐8 inhibits the activation of JNK‐NK‐κB pathway. (a and b) Western blot detection of brain JNK and p‐JNK levels after MCAO and intraperitoneal injection of vehicle or JNK‐IN‐8. (c and d) Western blot analysis of brain p65 levels after MCAO and intraperitoneal injection of vehicle or JNK‐IN‐8. (e and f) Western blot analysis of brain I‐kBa levels after MCAO and intraperitoneal injection of vehicle or JNK‐IN‐8. MCAO, middle cerebral artery occlusion; p‐JNK, phosphorylated c‐Jun N‐terminal kinase. *p < .05